Cure My Disease

Don't miss your cure!

 Log in / Sign up

New digital health tool aims to simplify care for patients with multiple chronic illnesses

NCT ID NCT07400133

Knowledge-focused Sponsor: Centre for Chronic Disease Control, India Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new digital health tool designed to help adults aged 40 and older who have two or more long-term health conditions, like high blood pressure, diabetes, or depression. The tool includes an electronic system to guide doctors, telemedicine for specialist visits, and a mobile app for patients. About 180 people in India and Nepal will use the tool for three months, and researchers will check if it is easy to use and helpful.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 180 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Feb 2026

An estimate. Start dates often move.

Expected to finish

May 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population includes adult patients with multiple long-term conditions and primary health care providers from six rural primary health centres in India and Nepal. Study sites include two centres each in Jodhpur, Rajasthan; Anakapalli, Andhra Pradesh; and Bagmathi provience, Nepal. At each site, approximately 30 patients with multiple long-term conditions and all participating health care providers will be enrolled. Patients will be recruited from routine care at participating primary health centres, and providers will be recruited from staff involved in delivering the intervention.

Ages

40 to 100 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 40 years or above * Attending the Primary Health Centre (PHC) during the enrollment period * Diagnosed with two or more of the following chronic conditions: 1. Hypertension 2. Diabetes mellitus 3. Depression 4. Anxiety 5. Chronic obstructive pulmonary disease (COPD) 6. Asthma 7. Vision impairment 8. Hearing impairment 9. Osteoarthritis 10. Chronic back pain Exclusion Criteria: * Age \< 40 years * Presence of only one or none of the listed chronic conditions * Pregnant or breastfeeding women * Severe cognitive impairment or dementia that prevents informed consent or or reliable participation * Bedridden or terminally ill individuals with a life expectancy \< 6 month * Current participation in another clinical or interventional research study may interfere with study outcomes * Severe psychiatric illness (e.g., psychosis or bipolar disorder) other than depression or anxiety * Unable or unwilling to provide written informed consent * Severe communication barriers that prevent participation in interviews or questionnaires, even with assistance

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anxiety are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anxiety asthma Behavior cardiovascular disorder chronic obstructive pulmonary disease depressive disorder diabetes mellitus disorder of ear disorder of orbital region Ear Diseases eye disorder hearing loss disorder hypertensive disorder metabolic disease neurodevelopmental disorder osteoarthritis Respiration Disorders respiratory system disorder vision disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Diseases of the circulatory system Diseases of the ear and mastoid process Diseases of the eye and adnexa Diseases of the musculoskeletal system and connective tissue Diseases of the respiratory system Endocrine, nutritional and metabolic diseases Mental, behavioral and neurodevelopmental disorders

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    6 sites in 2 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Beru,Primary Health Care Center

    Bhopālgarh, Jodupur, 342024, India

  • Dadhikot Primary Health Care Center

    Bhaktapur, Bagmati, 45206, Nepal

  • Kathmandu, Urban health promotion center

    Kathmandu, Bagmati, 1244600, Nepal

  • Makavarapalem Primary Health Care Center

    Narsīpatnam, Anakapalli, 531113, India

  • Nathavaram Primary Health Care Center

    Narsīpatnam, Anakapalli, 531115, India

  • Pheench, Primary Health Care Center

    Phalodi, Jodupur, 342801, India

More trials for these conditions

Other studies related to the condition(s) this trial covers.